In present study, although the rate of BCL2 gene rearrangements was high in DLBCL patients with HBV infection, multivariable analysis showed that BCL2 gene rearrangements was not an independent adverse prognostic factor. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.